DIABETIC INTERSTITIAL GLUCOSE IN THE SKIN TISSUE BY ATR-FTIR SPECTROSCOPY VERSUS CAPILLARY BLOOD GLUCOSE

NATALJA SKREBOVA EIKJE

doi:10.1142/s1793545810000903

[1] E. Cengiz, W. V. Tamborlane, “A tale of two compartments: Interstitial versus blood glucose monitoring,” Diabetes Technol. Ther. 11(1), S11–S15 (2009).

[2] N. S. Eikje, K. Aizawa, T. Sota, Y. Ozaki, S. Arase, “Identification and characterization of skin biomolecules for drug targeting and monitoring by vibrational spectroscopy,” TOMCJ. 2, 38–48 (2008).

[3] N. S. Eikje, T. Sota, K. Aizawa, “Cutaneous approach towards clinical and pathophysiological aspects of hyperglycemia by ATR-FTIR spectroscopy,” in Diagnostic Optical Spectroscopy in Biomedicine IV, D. Schweitzer, M. Fitzmaurice, Eds., Proceedings of SPIE, the International Society for Optical Engineering, Washington, USA 6628, 66281M (2007).

[4] Pike Technologies Inc., Instrumentation (from Installation and User Guide).

[5] C. Inada, M. Kanazawa, K. Aizawa, “Measurement of glucose concentrations by infrared spectroscopy method,” Tokyo Medical University Journal 61(2), 146–153 (2003).

[6] R. K. Dukor, Vol. 5 in Handbook of Vibrational Spectroscopy; J. M. Chalmers, P. R. Griffiths, Eds., John Wiley & Sons Ltd., pp. 3335–3361 (2002).

[7] N. S. Eikje, “In vivo interstitial glucose characterization and monitoring by ATR-FTIR Spectroscopy,” to be published.